drugset / Trial / NCT00210093
A Pharmacokinetic Evaluation Study in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous, intranasal, and inhalation administration and to calculate the relative bioavailability of INS37217 when administered via oral or nasal inhalation.
Timeline
- Start
- 2003-04
- Primary completion
- 2003-05
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | denufosol | Other / unclassified | — | Intravenous |
Indications
No indication recorded.